SBI Securities’s AgomAb Therapeutics NV AGMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22 Hold
2
– – ﹤0.01% 3900
2026
Q2
$26 Hold
2
– – ﹤0.01% 3801
2026
Q1
$21 Buy
+2
New +$28 ﹤0.01% 3762

Other funds holding AGMB

SBI Securities's AGMB Position: Q3 2026 in Review

SBI Securities held its AgomAb Therapeutics NV (AGMB) position steady in Q3 2026 at 2 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #3900.

SBI Securities first reported a position in AGMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $26 in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.

  • SBI Securities held 2 shares of AgomAb Therapeutics NV worth $22 as of Q3 2026.
  • SBI Securities left its AgomAb Therapeutics NV share count unchanged in Q3 2026.
  • AgomAb Therapeutics NV made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3900 holding.
  • SBI Securities first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 3 quarters since.
  • SBI Securities's AgomAb Therapeutics NV position peaked at $26 in Q2 2026.
  • 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.